Eric Shahinian - Sep 28, 2022 Form 4 Insider Report for Pasithea Therapeutics Corp. (KTTA)

Role
Member of 10% owner group
Signature
/s/ Eric Shahinian
Stock symbol
KTTA
Transactions as of
Sep 28, 2022
Transactions value $
$76,299
Form type
4
Date filed
9/30/2022, 04:36 PM
Previous filing
Sep 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KTTA Common Stock Purchase $68.5K +57.6K +3.34% $1.19 1.78M Sep 28, 2022 See footnote F1
transaction KTTA Common Stock Purchase $7.76K +6.71K +0.38% $1.16 1.79M Sep 29, 2022 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by Camac Fund, LP. ("Camac Fund"). Eric Shahinian is the managing member of Camac Capital, LLC, which is the general partner of Camac Fund and the managing member of Camac Partners, LLC.